Timo Mayerhöfer

8PUBLICATIONS
13CO-AUTHORS
Infectious diseasesCentral nervous systemRespiratory diseasesInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 31, 2025
Differences in the Phenotype of Bacterial and Viral Sepsis-A Prospective, Multicenter, Observational Study.

Fabian Perschinka, Georg Franz Lehner, Timo Mayerhöfer

|Jul 30, 2025
Soluble Neuropilin-1 as a Marker for Distinguishing Bacterial and Viral Sepsis in Critically Ill Patients-A Prospective, Multicenter, Observational Study.

Fabian Perschinka, Georg Franz Lehner, Timo Mayerhöfer

|May 13, 2025
High bicarbonate replacement fluid and time to pH normalization during continuous veno-venous hemofiltration with regional citrate anticoagulation: a retrospective single-center cohort study.

Timo Mayerhöfer, Paul Köglberger, Fabian Perschinka

|Jan 25, 2025
Impact of mechanical ventilation on severe acute kidney injury in critically ill patients with and without COVID-19 - a multicentre propensity matched analysis.

Fabian Perschinka, Timo Mayerhöfer, Teresa Engelbrecht

|Nov 10, 2023
Outcome of COVID-19 patients treated with VV-ECMO in Tyrol during the pandemic.

Andreas Peer, Fabian Perschinka, Georg Lehner

|Jan 08, 2023
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data.

Cornelia Lass-Flörl, Miriam Knoll, Wilfried Posch

Pageof 2

Frequent Collaborators

7 joint publications

Michael Joannidis

4 joint publications

Fabian Perschinka

2 joint publications

Wilfried Posch

2 joint publications

Cornelia Lass-Flörl